WorldQuant Millennium Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-154,852
| Closed | -$21.1M | – | 481 |
|
|
2024
Q4 | $21.1M | Buy |
154,852
+47,370
| +44% | +$6.47M | 0.14% | 177 |
|
|
2024
Q3 | $12.4M | Sell |
107,482
-51,003
| -32% | -$5.88M | 0.09% | 215 |
|
|
2024
Q2 | $21.8M | Buy |
158,485
+89,024
| +128% | +$12.3M | 0.2% | 142 |
|
|
2024
Q1 | $9.58M | Buy |
69,461
+50,766
| +272% | +$7M | 0.12% | 198 |
|
|
2023
Q4 | $2.46M | Sell |
18,695
-3,031
| -14% | -$399K | 0.03% | 264 |
|
|
2023
Q3 | $2.44M | Sell |
21,726
-97,430
| -82% | -$11M | 0.04% | 267 |
|
|
2023
Q2 | $11.2M | Sell |
119,156
-149,155
| -56% | -$14.1M | 0.19% | 161 |
|
|
2023
Q1 | $27.2M | Buy |
268,311
+17,239
| +7% | +$1.74M | 0.5% | 74 |
|
|
2022
Q4 | $30M | Buy |
251,072
+160,466
| +177% | +$19.2M | 0.68% | 35 |
|
|
2022
Q3 | $9.62M | Buy |
+90,606
| New | +$9.62M | 0.23% | 131 |
|
|
2020
Q3 | – | Sell |
-103,004
| Closed | -$12.6M | – | 352 |
|
|
2020
Q2 | $12.6M | Sell |
103,004
-30,740
| -23% | -$3.75M | 0.29% | 116 |
|
|
2020
Q1 | $11.6M | Buy |
133,744
+128,234
| +2,327% | +$11.1M | 0.28% | 116 |
|
|
2019
Q4 | $592K | Buy |
+5,510
| New | +$592K | 0.01% | 297 |
|